In this workshop, we will showcase the design and performance of the QuantideX® qPCR ESR1 exoMutation Kit* combined with the ExoLution Plus cfDNA/exosomal RNA Isolation Kit* to deliver sensitivity of ≤0.1% for 11 ESR1 mutations located in the ligand-binding domain, utilizing the power of cfDNA and exosomal RNA isolated from exosomes to deliver best in class performance.

Speaker:
Brian Haynes, PhD
Chief Scientific Officer,
Bio-Techne Diagnostics Division